These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 20179234

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer.
    Bostner J, Ahnström Waltersson M, Fornander T, Skoog L, Nordenskjöld B, Stål O.
    Oncogene; 2007 Oct 25; 26(49):6997-7005. PubMed ID: 17486065
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.
    Søiland H, Skaland I, Varhaug JE, Kørner H, Janssen EA, Gudlaugsson E, Baak JP, Søreide JA.
    Acta Oncol; 2009 Oct 25; 48(4):514-21. PubMed ID: 19107621
    [Abstract] [Full Text] [Related]

  • 8. P21-activated kinase 1 regulation of estrogen receptor-alpha activation involves serine 305 activation linked with serine 118 phosphorylation.
    Rayala SK, Talukder AH, Balasenthil S, Tharakan R, Barnes CJ, Wang RA, Aldaz CM, Khan S, Kumar R.
    Cancer Res; 2006 Feb 01; 66(3):1694-701. PubMed ID: 16452229
    [Abstract] [Full Text] [Related]

  • 9. Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients.
    Kirkegaard T, McGlynn LM, Campbell FM, Müller S, Tovey SM, Dunne B, Nielsen KV, Cooke TG, Bartlett JM.
    Clin Cancer Res; 2007 Mar 01; 13(5):1405-11. PubMed ID: 17332282
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ratio of 17HSD1 to 17HSD2 protein expression predicts the outcome of tamoxifen treatment in postmenopausal breast cancer patients.
    Jansson A, Delander L, Gunnarsson C, Fornander T, Skoog L, Nordenskjöld B, Stål O.
    Clin Cancer Res; 2009 May 15; 15(10):3610-6. PubMed ID: 19401349
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. HER2 status in hormone receptor positive premenopausal primary breast cancer adds prognostic, but not tamoxifen treatment predictive, information.
    Rydén L, Landberg G, Stål O, Nordenskjöld B, Fernö M, Bendahl PO.
    Breast Cancer Res Treat; 2008 May 15; 109(2):351-7. PubMed ID: 17636399
    [Abstract] [Full Text] [Related]

  • 15. Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.
    Girault I, Lerebours F, Amarir S, Tozlu S, Tubiana-Hulin M, Lidereau R, Bièche I.
    Clin Cancer Res; 2003 Apr 15; 9(4):1259-66. PubMed ID: 12684393
    [Abstract] [Full Text] [Related]

  • 16. A phosphorylation code for oestrogen receptor-alpha predicts clinical outcome to endocrine therapy in breast cancer.
    Skliris GP, Nugent ZJ, Rowan BG, Penner CR, Watson PH, Murphy LC.
    Endocr Relat Cancer; 2010 Sep 15; 17(3):589-97. PubMed ID: 20418363
    [Abstract] [Full Text] [Related]

  • 17. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO, Collett K, Tretli S, Akslen LA, Grotmol T.
    APMIS; 2009 Sep 15; 117(9):644-50. PubMed ID: 19703124
    [Abstract] [Full Text] [Related]

  • 18. Phospho-serine-118 estrogen receptor-alpha expression is associated with better disease outcome in women treated with tamoxifen.
    Murphy LC, Niu Y, Snell L, Watson P.
    Clin Cancer Res; 2004 Sep 01; 10(17):5902-6. PubMed ID: 15355923
    [Abstract] [Full Text] [Related]

  • 19. Long-term pattern of disease recurrence among patients with early-stage breast cancer according to estrogen receptor status and use of adjuvant tamoxifen.
    Khoshnoud MR, Fornander T, Johansson H, Rutqvist LE.
    Breast Cancer Res Treat; 2008 Jan 01; 107(1):71-8. PubMed ID: 18043896
    [Abstract] [Full Text] [Related]

  • 20. Microtubule-associated protein-tau is a bifunctional predictor of endocrine sensitivity and chemotherapy resistance in estrogen receptor-positive breast cancer.
    Andre F, Hatzis C, Anderson K, Sotiriou C, Mazouni C, Mejia J, Wang B, Hortobagyi GN, Symmans WF, Pusztai L.
    Clin Cancer Res; 2007 Apr 01; 13(7):2061-7. PubMed ID: 17404087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.